Xencor, Inc. (XNCR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD

Add to watchlist

23.03

+0.57

(+2.54%)

At close: 04:00PM EDT

23.03

0.00

(0.00%)

After hours:

04:03PM EDT

Loading interactive chart...

Simply Wall St.
Xencor First Quarter 2024 Earnings: Misses Expectations
Xencor ( NASDAQ:XNCR ) First Quarter 2024 Results Key Financial Results Revenue: US$12.8m (down 33% from 1Q 2023). Net...
GuruFocus.com
Xencor Inc (XNCR) Q1 2024 Earnings: Misses Revenue and Earnings Estimates
Comprehensive Analysis of Financial Performance and Strategic Initiatives
Business Wire
Xencor Reports First Quarter 2024 Financial Results
PASADENA, Calif., May 09, 2024--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and other serious diseases, today reported financial results for the first quarter ended March 31, 2024 and provided a review of recent clinical and business highlights.